COPE-ICD: a randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and population

Selina K Berg, Jesper H Svendsen, Ann-Dorthe Zwisler, Birthe D Pedersen, Pernille Preisler, Lone Siersbæk-Hansen, Mette B Hansen, Rune H Nielsen, Preben U Pedersen, Selina K Berg, Jesper H Svendsen, Ann-Dorthe Zwisler, Birthe D Pedersen, Pernille Preisler, Lone Siersbæk-Hansen, Mette B Hansen, Rune H Nielsen, Preben U Pedersen

Abstract

Background: Growing evidence exists that living with an ICD can lead to fear and avoidance behaviour including the avoidance of physical activity. It has been suggested that psychological stress can increase the risk of shock and predict death. Small studies have indicated a beneficial effect arising from exercise training and psychological intervention, therefore a large-scale rehabilitation programme was set up.

Methods/design: A mixed methods embedded experimental design was chosen to include both quantitative and qualitative measures. A randomised clinical trial is its primary component. 196 patients (power-calculated) were block randomised to either a control group or intervention group at a single centre. The intervention consists of a 1-year psycho-educational component provided by two nurses and a 12-week exercise training component provided by two physiotherapists. Our hypothesis is that the COPE-ICD programme will reduce avoidance behaviour, sexual dysfunction and increase quality of life, increase physical capability, reduce the number of treatment-demanding arrhythmias, reduce mortality and acute re-hospitalisation, reduce sickness leading to absence from work and be cost-effective. A blinded investigator will perform all physical tests and data collection.

Discussion: Most participants are men (79%) with a mean age of 58 (range 20-85). Most ICD implantations are on primary prophylactic indication (66%). 44% is NYHA II. Mean walk capacity (6MWT) is 417 m. Mean perception of General Health (SF-36) is PCS 42.6 and MCS 47.1.A large-scale ICD rehabilitation trial including psycho-educational intervention and exercise training has been initiated and will report findings starting in 2011.

Trial registration: ClinicalTrials.gov: NCT00569478.

Figures

Figure 1
Figure 1
Trial Design.
Figure 2
Figure 2
Timeline.
Figure 3
Figure 3
Flowchart of Patients Included in COPE-ICD.

References

    1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. American College of Cardiology American Heart Association Task Force European Society of Cardiology Committee for Practice Guidelines European Heart Rhythm Association Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006;11:746–837.
    1. Al-Khatib SM, Sanders GD, Carlson M, Cicic A, Curtis A, Fonarow GC, Groeneveld PW, Hayes D, Heidenreich P, Mark D, Peterson E, Prystowsky EN, Sager P, Salive ME, Thomas K, Yancy CW, Zareba W, Zipes D. Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. Am Heart J. 2008;11:613–622. doi: 10.1016/j.ahj.2008.05.027.
    1. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation. 2000;11:1660–1664.
    1. Thomas SA, Friedmann E, Kelley FJ. Living with an implantable cardioverter-defibrillator: a review of the current literature related to psychosocial factors. AACN Clin Issues. 2001;11:156–163. doi: 10.1097/00044067-200102000-00015.
    1. Sears SF Jr, Todaro JF, Lewis TS, Sotile W, Conti JB. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol. 1999;11:481–489. doi: 10.1002/clc.4960220709.
    1. Lemon J, Edelman S, Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung. 2004;11:176–182. doi: 10.1016/j.hrtlng.2004.02.005.
    1. Sears SF, Lewis TS, Kuhl EA, Conti JB. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics. 2005;11:451–457. doi: 10.1176/appi.psy.46.5.451.
    1. Godemann F, Butter C, Lampe F, Linden M, Werner S, Behrens S. Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD) Qual Life Res. 2004;11:411–416.
    1. Steinberg JS, Arshad A, Kowalski M, Kukar A, Suma V, Vloka M, Ehlert F, Herweg B, Donnelly J, Philip J, Reed G, Rozanski A. Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the World Trade Center attack. J Am Coll Cardiol. 2004;11:1261–1264. doi: 10.1016/j.jacc.2004.06.032.
    1. Shedd OL, Sears SF Jr, Harvill JL, Arshad A, Conti JB, Steinberg JS, Curtis AB. The World Trade Center attack: increased frequency of defibrillator shocks for ventricular arrhythmias in patients living remotely from New York City. J Am Coll Cardiol. 2004;11:1265–1267. doi: 10.1016/j.jacc.2004.04.058.
    1. Kohn CS, Petrucci RJ, Baessler C, Soto DM, Movsowitz C. The effect of psychological intervention on patients' long-term adjustment to the ICD: a prospective study. Pacing Clin Electrophysiol. 2000;11:450–456. doi: 10.1111/j.1540-8159.2000.tb00826.x.
    1. Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry. 2008;11:1324–1330. doi: 10.1001/archpsyc.65.11.1324.
    1. Davids JS, McPherson CA, Earley C, Batsford WP, Lampert R. Benefits of cardiac rehabilitation in patients with implantable cardioverter-defibrillators: a patient survey. Arch Phys Med Rehabil. 2005;11:1924–1928. doi: 10.1016/j.apmr.2005.04.009.
    1. Dougherty CM, Glenny R, Kudenchuk PJ. Aerobic exercise improves fitness and heart rate variability after an implantable cardioverter defibrillator. J Cardiopulm Rehabil Prev. 2008;11:307–311.
    1. Belardinelli R, Capestro F, Misiani A, Scipione P, Georgiou D. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Eur J Cardiovasc Prev Rehabil. 2006;11:818–825. doi: 10.1097/01.hjr.0000230104.93771.7d.
    1. Vanhees L, Kornaat M, Defoor J, Aufdemkampe G, Schepers D, Stevens A, Van Exel H, Van Den Beld J, Heidbuchel H, Fagard R. Effect of exercise training in patients with an implantable cardioverter defibrillator. Eur Heart J. 2004;11:1120–1126. doi: 10.1016/j.ehj.2004.04.034.
    1. Vanhees L, Schepers D, Heidbuchel H, Defoor J, Fagard R. Exercise performance and training in patients with implantable cardioverter-defibrillators and coronary heart disease. Am J Cardiol. 2001;11:712–715. doi: 10.1016/S0002-9149(00)01488-0.
    1. Fan S, Lyon CE, Savage PD, Ozonoff A, Ades PA, Balady GJ. Outcomes and adverse events among patients with implantable cardiac defibrillators in cardiac rehabilitation: a case-controlled study. J Cardiopulm Rehabil Prev. 2009;11:40–43.
    1. Crossmann A, Schulz SM, Kuhlkamp V, Ritter O, Neuser H, Schumacher B, Bauer W, Pauli P. A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator. Psychosom Med. 2010;11:434–441. doi: 10.1097/PSY.0b013e3181d9bcec.
    1. Dougherty CM, Lewis FM, Thompson EA, Baer JD, Kim W. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004;11:1594–1602. doi: 10.1111/j.1540-8159.2004.00691.x.
    1. Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD, O'Brien MC, Weintraub WS. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol. 2009;11:1259–1271. doi: 10.1111/j.1540-8159.2009.02495.x.
    1. Kuhl EA, Sears SF, Vazquez LD, Conti JB. Patient-assisted computerized education for recipients of implantable cardioverter defibrillators: a randomized controlled trial of the PACER program. J Cardiovasc Nurs. 2009;11:225–231.
    1. Lewin RJ, Coulton S, Frizelle DJ, Kaye G, Cox H. A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions. Heart. 2009;11:63–69.
    1. Dickerson SS, Wu YW, Kennedy MC. A CNS-facilitated ICD support group: a clinical project evaluation. Clin Nurse Spec. 2006;11:146–153. doi: 10.1097/00002800-200605000-00013.
    1. Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety. 1999;11:163–168. doi: 10.1002/(SICI)1520-6394(1999)9:4<163::AID-DA3>;2-B.
    1. Frizelle DJ, Lewin RJ, Kaye G, Hargreaves C, Hasney K, Beaumont N, Moniz-Cook E. Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: a pilot study. Br J Health Psychol. 2004;11:381–392.
    1. Fitchet A, Doherty PJ, Bundy C, Bell W, Fitzpatrick AP, Garratt CJ. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart. 2003;11:155–160. doi: 10.1136/heart.89.2.155.
    1. Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. Thousand Oaks, Calif.: SAGE Publications; 2007.
    1. Parse RR. The human becoming school of thought: a perspective for nurses and other health professionals. Thousand Oaks, Calif.: Sage; 1998.
    1. Perk J, Mathes P, Gohlke H, Monpére C, Hellemans I, McGee H, Sellier P, Saner H, eds. Cardiovascular Prevention and Rehabilitation. London: Springer-Verlang; 2007.
    1. Tabet JY, Meurin P, Ben Driss A, Thabut G, Weber H, Renaud N, Odjinkem N, Solal AC. Determination of exercise training heart rate in patients on beta-blockers after myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2006;11:538–543. doi: 10.1097/01.hjr.0000209813.05573.4d.
    1. Lampman RM, Knight BP. Prescribing exercise training for patients with defibrillators. Am J Phys Med Rehabil. 2000;11:292–297. doi: 10.1097/00002060-200005000-00012.
    1. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;11:473–483. doi: 10.1097/00005650-199206000-00002.
    1. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;11:247–263. doi: 10.1097/00005650-199303000-00006.
    1. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee to Update the 1997 Exercise Testing Guidelines. ACC/AHA 2002 guideline update for exercise testing: summary article. J Am Coll Cardiol. 2002;11:1531–1540. doi: 10.1016/S0735-1097(02)02164-2. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines)
    1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;11:111–117.
    1. Wright DJ, Khan KM, Gossage EM, Saltissi S. Assessment of a low-intensity cardiac rehabilitation programme using the six-minute walk test. Clin Rehabil. 2001;11:119–124. doi: 10.1191/026921501671364449.
    1. Ferrans CE, Powers MJ. Quality of life index: development and psychometric properties. ANS Adv Nurs Sci. 1985;11:15–24.
    1. Beery TA, Baas LS, Matthews H, Burroughs J, Henthorn R. Development of the implanted devices adjustment scale. Dimens Crit Care Nurs. 2005;11:242–248. doi: 10.1097/00003465-200509000-00012.
    1. Steinke EE, Gill-Hopple K, Valdez D, Wooster M. Sexual concerns and educational needs after an implantable cardioverter defibrillator. Heart Lung. 2005;11:299–308. doi: 10.1016/j.hrtlng.2005.03.002.
    1. Polit DFHBP. Essentials of Nursing Research, Methods, Appraisal, and Utilization. Lippincott; 1997.
    1. Ricoeur P. Time and narrative. The University of Chicago Press; 1988.
    1. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000;11:1064–1069. doi: 10.1016/S0140-6736(00)02039-0.
    1. Kruse M, Hochstrasser S, Zwisler AD, Kjellberg J. Comprehensive cardiac rehabilitation: a cost assessment based on a randomized clinical trial. Int J Technol Assess Health Care. 2006;11:478–483.
    1. World Medical Association Declaration of Helsinki. ethical principles for medical research involving human subjects. JAMA. 2000;11:3043–3045.
    1. Gibbons L, Blair SN, Kohl HW, Cooper K. The safety of maximal exercise testing. Circulation. 1989;11:846–852.
    1. Steinberg JS, Joshi S, Schron EB, Powell J, Hallstrom A, McBurnie M. AVID Investigators. Psychosocial status predicts mortality in patients with life-threatening ventricular arrhythmias. Heart Rhythm. 2008;11:361–365. doi: 10.1016/j.hrthm.2007.11.010.
    1. Kao CW, Friedmann E, Thomas SA. Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators. Qual Life Res. 2010;11:307–315. doi: 10.1007/s11136-010-9596-6.
    1. Kim JS, Pressler SJ, Welch JL, Damush T, Sloan RS, Wu J, Groh WJ. Physical function of patients with implantable cardioverter-defibrillators. J Cardiovasc Nurs. 2009;11:398–409.
    1. Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR. Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation. 2004;11:2864–2868. doi: 10.1161/01.CIR.0000146336.92331.D1.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel